Short Interest in AMERISAFE, Inc. (NASDAQ:AMSF) Decreases By 16.7%

AMERISAFE, Inc. (NASDAQ:AMSFGet Rating) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 227,500 shares, a decrease of 16.7% from the March 31st total of 273,200 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 100,800 shares, the short-interest ratio is currently 2.3 days.

Institutional investors and hedge funds have recently modified their holdings of the stock. Pinebridge Investments L.P. purchased a new stake in AMERISAFE in the 4th quarter worth $59,000. Belpointe Asset Management LLC bought a new stake in shares of AMERISAFE in the fourth quarter worth about $101,000. Advisor Group Holdings Inc. lifted its position in shares of AMERISAFE by 44.8% in the third quarter. Advisor Group Holdings Inc. now owns 1,823 shares of the insurance provider’s stock worth $102,000 after buying an additional 564 shares in the last quarter. SG Americas Securities LLC bought a new position in AMERISAFE during the first quarter valued at approximately $147,000. Finally, Captrust Financial Advisors grew its holdings in AMERISAFE by 121.2% during the 3rd quarter. Captrust Financial Advisors now owns 2,666 shares of the insurance provider’s stock valued at $150,000 after buying an additional 1,461 shares in the last quarter. 96.52% of the stock is currently owned by institutional investors.

Several brokerages have recently weighed in on AMSF. Zacks Investment Research cut shares of AMERISAFE from a “hold” rating to a “strong sell” rating and set a $40.00 price target on the stock. in a research note on Tuesday, March 8th. Truist Financial cut AMERISAFE from a “buy” rating to a “hold” rating and set a $50.00 target price on the stock. in a report on Friday, March 4th. Finally, StockNews.com initiated coverage on AMERISAFE in a report on Thursday, March 31st. They set a “hold” rating for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $53.33.

AMSF opened at $46.62 on Wednesday. The firm has a market cap of $902.56 million, a P/E ratio of 14.17 and a beta of 0.40. AMERISAFE has a 1-year low of $44.06 and a 1-year high of $67.10. The company has a 50 day simple moving average of $47.70 and a two-hundred day simple moving average of $52.21.

AMERISAFE (NASDAQ:AMSFGet Rating) last released its earnings results on Wednesday, April 27th. The insurance provider reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.16. AMERISAFE had a net margin of 20.70% and a return on equity of 12.83%. During the same quarter in the previous year, the business posted $0.76 EPS. Equities research analysts expect that AMERISAFE will post 2.55 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 17th will be paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date of this dividend is Thursday, June 16th. AMERISAFE’s dividend payout ratio (DPR) is 37.69%.

AMERISAFE Company Profile (Get Rating)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company's workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It serves small to mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Read More

Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.